Energizer® partners with Diabetes Australia 7 March 2016 Diabetes Australia is thrilled to announce a new partnership with Energizer® Australia. This new partnership will help to raise the profile of diabetes and Diabetes Australia in the hearts and minds of the general public. Energizer® has 120 years history of innovation with batteries and made the first ever handheld torch, the first Inductive Charger, and currently, the makers of the world’s longest lasting AA and AAA batteries in high tech devices (Energizer® Ultimate Lithium ™). Diabetes Australia CEO Professor Greg Johnson said it was very pleasing that more large companies and businesses like Energizer® were choosing to support the diabetes cause. “Diabetes is the fastest growing chronic condition in Australia†he said “another 100,000 Australians developed diabetes in just the past year and the impact of diabetes on families, productivity and the health system is very serious.†“Diabetes is often a silent condition in that many Australians have type 2 diabetes and don’t know it – they have not been diagnosed. Partnering with Energizer® means that diabetes will be more visible in supermarkets, pharmacies and retail outlets and this will make more people think about diabetes and their risk,†said Professor Greg Johnson. “We are delighted to partner with Diabetes Australia to help support the 1.7 million Australians currently thought to be living with diabetes†said David Pattinson, Marketing Director, Energizer®. Furthermore, Energizer® is donating $1 for every specially marked pack purchased to Diabetes Australia, to help fund the diabetes cause. Keep an eye out for the Energizer® shield and think about how you can support people affected by diabetes. Visit the Diabetes Australia website for more information staging.diabetesaustralia.com.au
News 27 May 2026 Urgent product correction for MiniMed Android App Medtronic and the Therapeutic Goods Administration have issued an Urgent Product Correction for a MiniMed Mobile App Android software version... Continue Reading
News 27 May 2026 Tzield listing a game-changer for early-stage type 1 diabetes The first new therapy for type 1 diabetes in nearly a century, which works to delay the need for insulin therapy in type 1 diabetes, has been approved for use in Australia by the Therapeutic Goods Administration. Continue Reading
News 27 May 2026 Important recall: Selected Omnipod® 5 and Omnipod DASH® Pods Insulet has issued a critical recall affecting specific lots of Omnipod 5 and Omnipod DASH Pods after identifying a manufacturing... Continue Reading